Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRO
Marathon Oil Corporation
MRO
|
+$180M |
| 2 |
BHI
Baker Hughes
BHI
|
+$173M |
| 3 |
Dominion Energy
D
|
+$161M |
| 4 |
Kinder Morgan
KMI
|
+$155M |
| 5 |
Marathon Petroleum
MPC
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRX
FOREST LABORATORIES INC
FRX
|
+$177M |
| 2 |
SLB Ltd
SLB
|
+$121M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$119M |
| 4 |
PepsiCo
PEP
|
+$110M |
| 5 |
Mastercard
MA
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 15.14% |
| 2 | Healthcare | 12.64% |
| 3 | Financials | 8.59% |
| 4 | Utilities | 7.75% |
| 5 | Technology | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNI
976
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $8.2M | 0.02% |
104,941
+4,945
| +5% | +$398K |
|
|
RPRX
977
DELISTED
Repros Therapeutics Inc.
RPRX
| $8.19M | 0.02% |
+826,822
| New | +$12.2M |
|
978
CareTrust REIT
CTRE
$9.37B
| $8.17M | 0.02% |
571,526
+489,175
| +594% | +$8.29M |
|
|
BERY
979
DELISTED
Berry Global Group, Inc.
BERY
| $8.17M | 0.02% |
352,505
+129,218
| +58% | +$2.95M |
|
980
Banco Santander Chile
BSAC
$17B
| $8.17M | 0.02% |
+369,824
| New | +$9.16M |
|
981
TIM SA
TIMB
$8.69B
| $8.17M | 0.02% |
+311,706
| New | +$8.43M |
|
982
SLR Investment Corp
SLRC
$693M
| $8.14M | 0.02% |
436,015
+98,470
| +29% | +$1.98M |
|
|
SSI
983
DELISTED
Stage Stores Inc
SSI
| $8.13M | 0.02% |
475,144
+419,261
| +750% | +$7.51M |
|
|
AMCC
984
DELISTED
Applied Micro Circuits Corporation New
AMCC
| $8.11M | 0.02% |
1,158,161
+1,113,190
| +2,475% | +$9.63M |
|
985
PUT
Newmont
NEM
$139B
| $8.1M | 0.02% |
351,200
-50,500
| -13% | -$1.29M |
|
|
TPH
986
DELISTED
Tri Pointe Homes
TPH
| $8.09M | 0.02% |
625,521
+458,289
| +274% | +$6.52M |
|
|
ITG
987
DELISTED
Investment Technology Group Inc
ITG
| $8.09M | 0.02% |
513,296
-14,337
| -3% | -$250K |
|
|
K
988
CALL
DELISTED
Kellanova
K
| $8.08M | 0.02% |
139,728
-36,210
| -21% | -$2.18M |
|
989
Qualcomm
QCOM
$166B
| $8.07M | 0.02% |
107,977
-21,273
| -16% | -$1.63M |
|
990
Berkshire Hathaway Class A
BRK.A
$1.08T
| $8.07M | 0.02% |
39
+29
| +290% | +$5.79M |
|
991
JB Hunt Transport Services
JBHT
$24.4B
| $8.05M | 0.02% |
108,674
-192,102
| -64% | -$14.6M |
|
992
Sprouts Farmers Market
SFM
$8.03B
| $8.04M | 0.02% |
276,442
+243,858
| +748% | +$7.53M |
|
|
ETP
993
DELISTED
Energy Transfer Partners, L.P.
ETP
| $7.99M | 0.02% |
+165,500
| New | +$7.83M |
|
994
Flowserve
FLS
$10.2B
| $7.99M | 0.02% |
113,233
+33,920
| +43% | +$2.51M |
|
995
Pacira BioSciences
PCRX
$991M
| $7.95M | 0.02% |
81,999
-259,178
| -76% | -$25.2M |
|
996
Fair Isaac
FICO
$25.2B
| $7.92M | 0.02% |
+143,811
| New | +$8.48M |
|
997
Cal-Maine
CALM
$3.95B
| $7.92M | 0.02% |
+177,202
| New | +$7.03M |
|
|
BGG
998
DELISTED
Briggs & Stratton Corp.
BGG
| $7.89M | 0.02% |
437,720
+167,740
| +62% | +$3.28M |
|
|
CLVS
999
DELISTED
Clovis Oncology, Inc.
CLVS
| $7.88M | 0.02% |
173,627
+110,402
| +175% | +$4.61M |
|
1000
VanEck Gold Miners ETF
GDX
$32.2B
| $7.87M | 0.02% |
368,329
+51,545
| +16% | +$1.32M |
|
Similar funds
Israel Englander's Q3 2014 Portfolio in Review
As of Q3 2014, Israel Englander held 4,400 positions worth $39.5B, up 9.5% from $36.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander deployed $4.94B of net new capital in Q3 2014, opening 1,066 new positions and adding to 1,336 existing holdings. Its largest new stake was St Jude Medical: 1,407,737 shares worth $84.6M.
By sector, the portfolio is most concentrated in Energy at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was SLB Ltd, an estimated $121M trimmed.
- Israel Englander's largest Q3 2014 buy was St Jude Medical: 1,407,737 shares worth $84.6M.
- Israel Englander added most to Marathon Oil Corporation in Q3 2014, an estimated $180M increase.
- Israel Englander's biggest Q3 2014 reduction was SLB Ltd, cutting an estimated $121M.
- Israel Englander fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 11% of its $39.5B portfolio in Q3 2014.
- Israel Englander opened 1,066 new positions and closed 749 in Q3 2014.
- Israel Englander's portfolio value rose 9.5% quarter-over-quarter to $39.5B.
Based on Millennium Management's 13F filing for Q3 2014, filed 14 Nov 2014.